Related Experiment Video

Updated: Nov 22, 2025

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

483

Characteristics of Patients with Hypertension at a Nicaraguan Clinic

Jennifer S Lee, Mark Humphrey, Morgan Adams

    Journal of Health Care for the Poor and Underserved
    |January 8, 2021
    PubMed

    Insights

    Hypertension is prevalent in Nicaraguan ambulatory care patients, with common treatments including angiotensin-receptor blockers and angiotensin-converting enzyme inhibitors. This study characterized these patients and their medication management.

    Area of Science:

    • Clinical Medicine
    • Public Health
    • Pharmacology

    Background:

    • Hypertension is a significant global health concern, particularly in low-resource settings.
    • Understanding patient demographics and treatment patterns is crucial for effective hypertension management in ambulatory care.

    Purpose of the Study:

    • To describe the characteristics of hypertensive patients in a Nicaraguan ambulatory care clinic.
    • To identify the pharmacological management strategies employed for hypertension in this population.

    Main Methods:

    • A retrospective chart review of 349 adult patients from a Nicaraguan ambulatory care clinic.
    • Analysis of patients diagnosed with or having a history of hypertension.

    Main Results:

    • 19.77% of patients had a history of hypertension. Hypertensive patients were predominantly female (66.2%) with a mean age of 56.1 years.
    • Common comorbidities included type 2 diabetes mellitus (18.8%), chronic kidney disease (10%), and overweight/obesity (75.8%).
    • Losartan, captopril, and enalapril were the most frequently prescribed antihypertensive medications.

    Conclusions:

    • Hypertension is a common condition within this Nicaraguan clinic population.
    • Angiotensin-receptor blockers and angiotensin-converting enzyme inhibitors are the primary pharmacological treatments used.
    Abstract

    More Related Videos

    Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug05:57

    Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

    Published on: May 17, 2024

    978
    Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis05:52

    Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

    Published on: November 21, 2013

    15.2K

    Related Concept Videos

    Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

    Hypertension III: Clinical Manifestations and Diagnostic Studies

    Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
    215
    Hypertension V: Nursing Management01:23

    Hypertension V: Nursing Management

    The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
    170
    Hypertension I: Introduction01:28

    Hypertension I: Introduction

    Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
    353
    Hypertension II: Pathophysiology01:29

    Hypertension II: Pathophysiology

    Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
    362
    Factors affecting Blood pressure01:28

    Factors affecting Blood pressure

    Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
    Physiological Factors:
    5.8K
    Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

    Hypertension IV: Drug Therapy and Lifestyle Modifications

    Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
    306